Bad  ||| S:0 E:4 ||| JJ
for  ||| S:4 E:8 ||| IN
Breathing ||| S:8 E:17 ||| NNP
:  ||| S:17 E:19 ||| :
A  ||| S:19 E:21 ||| DT
Pictorial  ||| S:21 E:31 ||| NNP
of  ||| S:31 E:34 ||| IN
Drug-Induced  ||| S:34 E:47 ||| NNP
Pulmonary  ||| S:47 E:57 ||| NNP
Disease  ||| S:57 E:65 ||| NNP
Drug-induced  ||| S:65 E:78 ||| JJ
lung  ||| S:78 E:83 ||| NN
disease  ||| S:83 E:91 ||| NN
has  ||| S:91 E:95 ||| VBZ
been  ||| S:95 E:100 ||| VBN
described  ||| S:100 E:110 ||| VBN
with  ||| S:110 E:115 ||| IN
over  ||| S:115 E:120 ||| IN
300  ||| S:120 E:124 ||| CD
different  ||| S:124 E:134 ||| JJ
agents ||| S:134 E:140 ||| NNS
,  ||| S:140 E:142 ||| ,
some  ||| S:142 E:147 ||| DT
of  ||| S:147 E:150 ||| IN
which  ||| S:150 E:156 ||| WDT
are  ||| S:156 E:160 ||| VBP
asymptomatic  ||| S:160 E:173 ||| VBN
and  ||| S:173 E:177 ||| CC
may  ||| S:177 E:181 ||| MD
first  ||| S:181 E:187 ||| RB
present  ||| S:187 E:195 ||| VB
on  ||| S:195 E:198 ||| IN
imaging ||| S:198 E:205 ||| NN
.  ||| S:205 E:207 ||| .
These  ||| S:207 E:213 ||| DT
pulmonary  ||| S:213 E:223 ||| JJ
diseases  ||| S:223 E:232 ||| NNS
may  ||| S:232 E:236 ||| MD
present  ||| S:236 E:244 ||| VB
with  ||| S:244 E:249 ||| IN
variable  ||| S:249 E:258 ||| JJ
imaging  ||| S:258 E:266 ||| NN
manifestations ||| S:266 E:280 ||| NNS
,  ||| S:280 E:282 ||| ,
and  ||| S:282 E:286 ||| CC
often  ||| S:286 E:292 ||| RB
overlap  ||| S:292 E:300 ||| VB
with  ||| S:300 E:305 ||| IN
other  ||| S:305 E:311 ||| JJ
etiologies  ||| S:311 E:322 ||| JJ
such  ||| S:322 E:327 ||| JJ
as  ||| S:327 E:330 ||| IN
rejection ||| S:330 E:339 ||| NN
,  ||| S:339 E:341 ||| ,
lymphoproliferative  ||| S:341 E:361 ||| JJ
disorders ||| S:361 E:370 ||| NNS
,  ||| S:370 E:372 ||| ,
and  ||| S:372 E:376 ||| CC
infection  ||| S:376 E:386 ||| NN
that  ||| S:386 E:391 ||| WDT
may  ||| S:391 E:395 ||| MD
be  ||| S:395 E:398 ||| VB
suspected  ||| S:398 E:408 ||| VBN
in  ||| S:408 E:411 ||| IN
this  ||| S:411 E:416 ||| DT
patient  ||| S:416 E:424 ||| JJ
population ||| S:424 E:434 ||| NN
.  ||| S:434 E:436 ||| .
However ||| S:436 E:443 ||| RB
,  ||| S:443 E:445 ||| ,
there  ||| S:445 E:451 ||| EX
are  ||| S:451 E:455 ||| VBP
several  ||| S:455 E:463 ||| JJ
drugs  ||| S:463 E:469 ||| NNS
that  ||| S:469 E:474 ||| WDT
have  ||| S:474 E:479 ||| VBP
classic  ||| S:479 E:487 ||| JJ
imaging  ||| S:487 E:495 ||| NN
appearances ||| S:495 E:506 ||| NNS
,  ||| S:506 E:508 ||| ,
and  ||| S:508 E:512 ||| CC
in  ||| S:512 E:515 ||| IN
the  ||| S:515 E:519 ||| DT
proper  ||| S:519 E:526 ||| JJ
clinical  ||| S:526 E:535 ||| JJ
context ||| S:535 E:542 ||| NN
,  ||| S:542 E:544 ||| ,
the  ||| S:544 E:548 ||| DT
radiologist  ||| S:548 E:560 ||| NN
should  ||| S:560 E:567 ||| MD
include  ||| S:567 E:575 ||| VB
their  ||| S:575 E:581 ||| PRP$
toxicity  ||| S:581 E:590 ||| NN
in  ||| S:590 E:593 ||| IN
the  ||| S:593 E:597 ||| DT
differential  ||| S:597 E:610 ||| JJ
diagnosis ||| S:610 E:619 ||| NN
,  ||| S:619 E:621 ||| ,
potentially  ||| S:621 E:633 ||| RB
expediting  ||| S:633 E:644 ||| JJ
withdrawal  ||| S:644 E:655 ||| NN
of  ||| S:655 E:658 ||| IN
the  ||| S:658 E:662 ||| DT
drug  ||| S:662 E:667 ||| NN
and  ||| S:667 E:671 ||| CC
avoiding  ||| S:671 E:680 ||| VBG
irreversible  ||| S:680 E:693 ||| JJ
lung  ||| S:693 E:698 ||| NN
injury  ||| S:698 E:705 ||| NN
such  ||| S:705 E:710 ||| JJ
as  ||| S:710 E:713 ||| IN
fibrosis ||| S:713 E:721 ||| NN
.  ||| S:721 E:723 ||| .
